SHARE

Creo Medical sales sees core progress, but misses expectations

The medical device company saw a 74% revenue increase in ‘Creo core technology’ to £4m. However full-year revenue will fall short of market predictions with expected sales of £30.4m for the year to 31 December, a 1.3% decrease from the previous year.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.